Table 3.
Characteristics at Listing | VAD (n=29) | ECMO (n=88) | Unsupported (n=1109) | P Value | VAD or ECMO at Listing (n=117) | VAD or ECMO After Listing (n=128) | P Value |
---|---|---|---|---|---|---|---|
Male sex | 16 (55.2) | 50 (56.8) | 635 (57.3) | 1.0 | 66 (56.4) | 79 (61.7) | 0.4 |
White race | 22 (75.9) | 56 (63.6) | 766 (69.1) | 0.4 | 78 (66.7) | 87 (68.0) | 0.8 |
Single ventricle | 7 (24.1) | 40 (45.5) | 674 (60.8) | <0.0001 | 47 (40.2) | 77 (60.2) | 0.002 |
Status 1A | 19 (95.0) | 78 (98.7) | 871 (86.8) | 0.005 | 97 (98.0) | 108 (93.1) | 0.09 |
Status 1B | 0 (0.0) | 0 (0.0) | 82 (8.2) | 0.01 | 0 (0.0) | 6 (5.2) | 0.02 |
PRA >10 | 6 (24.0) | 9 (11.7) | 297 (29.2) | 0.004 | 15 (14.7) | 29 (25.0) | 0.1 |
Ventilator at listing | 20 (71.4) | 78 (88.6) | 411 (38.7) | <0.0001 | 98 (84.5) | 60 (48.4) | <0.001 |
Inotropes at listing | 16 (59.3) | 66 (75.9) | 749 (67.6) | 0.2 | 82 (71.9) | 94 (73.4) | 0.8 |
History of surgery at listing | 25 (86.2) | 80 (90.9) | 825 (74.5) | 0.001 | 105 (89.7) | 93 (72.7) | <0.001 |
History of renal insufficiency | 2 (7.1) | 10 (11.6) | 52 (4.8) | 0.02 | 12 (10.5) | 4 (3.3) | 0.03 |
Age at listing, mo | 9.0±6.4 | 3.1±4.3 | 5.3±6.5 | <0.0001 | 4.5±5.5 | 5.1±5.7 | 0.5 |
Weight at listing, kg | 6.0±2.1 | 4.4±1.9 | 5.2±2.0 | 0.0001 | 4.8±2.0 | 5.2±2.0 | 0.1 |
Patients with weight <5 kg | 12 (41.4) | 65 (73.9) | 620 (55.9) | 0.001 | 77 (65.8) | 71 (55.5) | 0.1 |
Serum albumin, g/dL | 3.3±0.5 | 3.0±0.7 | 3.4±1.6 | 0.1 | 3.1±0.7 | 3.2±0.7 | 0.3 |
Bilirubin at listing, mg/dL | 0.8±0.8 | 3.0±5.0 | 1.7±2.7 | 0.0002 | 2.5±4.5 | 1.8±2.5 | 0.1 |
Creatinine at listing, mg/dL | 0.4±0.2 | 0.5±0.3 | 0.4±0.5 | 0.1 | 0.5±0.3 | 0.4±0.2 | <0.001 |
Transplant year | 2015.3±2.3 | 2014.9±2.6 | 2014.3±2.5 | 0.1 | 2015.0±2.5 | 2015.0±2.6 | 1.0 |
Data are given as number (percentage) or mean±SD. CHD indicates congenital heart disease; ECMO, extracorporeal membrane oxygenation; PRA, panel reactive antibody; and VAD, ventricular assist device.